Dyadic International, Inc. Partners With Scripps Florida To Annotate Dyadic’s Proprietary C1 Genome

JUPITER, Fla.--(BUSINESS WIRE)--March 31, 2006--Dyadic International, Inc. (AMEX:DIL), a biotechnology company, announced today that it has engaged The Scripps Research Institute to work with Dyadic scientists to provide a complete annotation of the genome of Dyadic’s proprietary fungal organism, Chrysosporium lucknowense (“C1"), which was sequenced by another vendor last year. The work will be carried out at the Scripps’ new research center in Palm Beach County, Florida, under the direction of Dr. Nick Tsinoremas, Senior Director of Informatics at Scripps Florida. Financial details of the agreement were not disclosed.

MORE ON THIS TOPIC